• Asia Broadband Inc., an experienced producer of precious metals is adding key gold mine property acquisitions in Mexico, while concurrently developing a proprietary cryptocurrency exchange
• The exchange will build a mechanism for holders of its gold-backed AABBG token to trade with major cryptocurrencies such as Bitcoin, Ethereum, and Litecoin
• The AABBG tokens launched in March, backed by $30 million in physical gold from the company’s properties
• The company reports it achieved several milestones in regard to the exchange’s development during the past month that were related to its network, platform, design and algorithms
• Asia Broadband expects to test the exchange in August and go live with it in September

Asia Broadband (OTC: AABB), a precious and base metals producer intent on developing a proprietary cryptocurrency exchange following the launch of its gold-backed AABBG cryptocurrency token, is reporting progress on the exchange’s creation. The company is backing its entry with $30 million in physical gold from its properties in Mexico, with the price of each token tied to whatever the existing price of one-tenth (0.1) gram of gold may be plus a 2 percent transaction fee  (https://ibn.fm/xqm2Q).

The AABBG token has dual advantages to purchasers. Though not a “stablecoin”, the token has stablecoin-like stability properties in that it is backed and supported by the company at minimum the .1 gram spot price of gold.  Additionally, the token will also have the price appreciation qualities of typical cryptocurrencies, once the proprietary exchange allows the token to be freely exchangeable.

According to a news release issued May 11 (https://ibn.fm/sU6Y3), the company achieved several milestones during the first month of developing the exchange’s network, platform, design and algorithms. Improvements included adding greater visitor capacity, enabling two-way transfers between the blockchain and the user’s wallet and establishing a more efficient mechanism for adding new currencies, completing the iOS, Android and web version designs, and putting the know your customer (“KYC”) protocols into motion for streamlining user and system processes.

The exchange will allow Asia Broadband wallet users to complete quick, two-way exchanges of their AABBG tokens for major cryptocurrencies such as Bitcoin, Ethereum and Litecoin.

According to the news release, the exchange will also augment transaction fee revenues and make it possible for the price of AABBG to appreciate based on market demand and the limits on the number of tokens in circulation.

Select cryptocurrencies have gained enormous value on the market in recent years despite instability that has seen their values fluctuate, and a growing number of investors has turned to the alternate form of money as a potential source of financial profile increase. Famed investors such as billionaire Stanley Druckenmiller predict that the U.S. dollar is on the verge of losing its status as the world’s reserve currency as the country faces the prospect of having to monetize its debt in order to meet its obligations, and some investors understandably prefer exchanges tethered to physical assets such as gold in order to increase their security and reduce volatility. (https://ibn.fm/PcDJe).

Asia Broadband’s exchange is planned for testing in mid-August and is expected to go live in early September. Before then, the company will work to complete its cold wallet, web versions of the wallet and exchange, transaction fee mechanism, trade platform and reporting system, according to the news release.

The Las Vegas-based company has acquired two mines — one in the Mexican state of Guerrero and another in the state of Colima. Its year-end fiscal report stated the company had a record annual gross profit of $16.8 million during 2020.

For more information, visit the company’s website at www.AsiaBroadbandInc.com.

NOTE TO INVESTORS: The latest news and updates relating to AABB are available in the company’s newsroom https://ibn.fm/AABB

 

• IP attorney Alan M. Weisberg, Esq., a partner of Christopher & Weisberg, to work with company
• HENC committed to ensuring that IP generates maximum return for shareholders
• BlackBox has developed a proprietary cannabis growing system based on aeroponic cultivation technology

Hero Technologies (OTC: HENC), a cannabis company focused on a vertically integrated strategy, announced that it has retained intellectual property attorney Alan M. Weisberg, Esq., a partner of Christopher & Weisberg, P.A. Weisberg will assist and advise the company as it focuses on protecting and monetizing the intellectual property of its subsidiary, BlackBox Systems and Technologies LLC (https://ibn.fm/1BCo9). “Solidifying our cannabis intellectual property rights is essential as we seek to monetize our proprietary growing systems,” said Hero Technologies CEO Gina Serkasevich. “Whether by protecting our competitive advantages—particularly in the cost structure and environmental impact of our cannabis operations—or to potentially license our technology for others to use, we want to ensure that our IP generates maximum return for our shareholders.” A registered patent attorney with more than 30 years of technical experience, Weisberg is a former engineer and consultant for IB and has been a featured presenter for the Daily Business Review‘s Intellectual Property Roundtable. He earned a JD, cum laude, and an MS in information systems from Pace University, and a BSEE degree from the Rochester Institute of Technology. BlackBox has developed a proprietary cannabis growing system based on aeroponic cultivation technology (https://ibn.fm/uqh5r). The system creates ideal cannabis growing conditions with a highly efficient use of materials that increases photosynthesis, produces large plant flowers, and optimizes harvests. The BlackBox system design features a high-pressure nutrient delivery system equipped with a UPS battery back-up. The patented innovations in BlackBox’s grow technology allow for the production of premium-grade cannabis at scale, resulting in increasing margins for both wholesalers and retailers while maintaining the highest consumer standards. Hero Technologies is looking for opportunities to acquire significant greenhouse and warehouse space that it can develop for cannabis cultivation and retail operations. The company plans to use its exclusive BlackBox technology for its cultivation projects. Hero Technologies is a cannabis company working toward a vertically integrated business model. The company owns a majority stake in BlackBox Systems and Technologies LLC, an aeroponic cannabis cultivation system that provides optimal growing conditions to enhance photosynthesis and cultivation of large flowering plants, creating increased harvest efficiencies. The company’s strategic business plan includes cannabis genetic engineering, farmland for both medical and recreational cannabis cultivation, production licenses, distribution licenses, consumer packaging, and retail and dispensary operations that make the company a multi-state operator (“MSO”). For more information, visit the company’s website at www.HeroTechnologiesInc.com. NOTE TO INVESTORS: The latest news and updates relating to HENC are available in the company’s newsroom at https://ibn.fm/HENC

• Completed acquisition of Acreage Florida, Inc and related owned and leased real estate assets
• Licensed to operate 35 dispensaries, a processing facility and a cultivation facility in Florida
• Florida cannabis market is poised for tremendous growth and it is forecasted to be a top 5 State by the year 2025

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), the torchbearer for a new, higher standard in the American cannabis industry, has announced its new subsidiary RWB Florida LLC, has completed the acquisition of Acreage Florida, Inc. and the related owned and leased real estate assets (https://ibn.fm/aUG1Q). This deal includes over 15 acres of land, a 114,000 SF facility for cultivation, a 4,000 SF freestanding administrative office building, and eight leased stores in prime locations throughout Florida. RWB is positioning itself to be one of the top three multi-state cannabis operators in the US legal cannabis and hemp market. The Company is on a mission to be the superior and most recognizable cannabis company in the US by holding itself to the highest ethical, manufacturing, education, branding and employment standards. “Our employees are impressed with Red White & Bloom’s commitment to the local communities as they expand their ESO program around the environment, jobs, social justice and governance,” stated Jim Frasier, Florida General Manager for RWB. “We are excited to play a major role in the benefits cannabis can bring to the state of Florida.” The Company is licensed to operate 35 dispensaries, a processing facility, and a cultivation facility in Florida. With 30 double-wide fully enclosed cultivation pods ready to deploy in the state, RWB plans to expedite the opening of additional medical marijuana dispensary locations and the implementation of home delivery (https://ibn.fm/T3R52). “The Florida cannabis market is poised for tremendous growth and is forecasted to be a top 5 State by the year 2025,” said Brad Rogers, CEO of RWB. “With approximately 450,000 medical cannabis patients currently registered in Florida, we see this as an amazing growth opportunity for the Company. Combine this with a population of 20M and we are delighted this deal has been finalized and look forward to delivering the highest quality medical products to the market.” The Company has currently completed or has definitive agreements for acquiring THC licensed entities in Michigan, Illinois, Florida, California, and Massachusetts. Once all acquisitions are completed, RWB will be available in 6 of the top 10 US states. For more information, visit the company’s website at www.RedWhiteBloom.com. NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://ibn.fm/RWBYF

• AmpliTech was tasked by Amplify My Probe with creating a special cryogenic probe head to facilitate studies on materials, molecules, and drugs
• The probe is expected to help speed up Electron Paramagnetic Resonance experiments by more than 100 times
• AmpliTech will be the exclusive manufacturer for the device, and Amplify My Probe will have sole global distribution rights for at least the first 18 months
• Since uplisting to NASDAQ in February 2021, AmpliTech has raised $30 million, creating a strong balance sheet and cash position for the company and allowing it to stay focused on growth and hedge against future market volatility

AmpliTech Group (NASDAQ: AMPG, AMPGW), a designer, developer and manufacturer of custom and standard state-of-the-art RF components for various markets including commercial, SATCOM, space, defense and military, received a significant developmental order for a special cryogenic probe head used to facilitate studies on materials, molecules, and drugs to treat diseases, among other applications (https://ibn.fm/PYlkm). The order was placed by Amplify My Probe, Ltd., a company that emerged from the Quantum Spin Dynamics group at the London Centre for Nanotechnology and UCLQ, and which specializes in commercializing technology to improve signal to noise ratio in Electron Paramagnetic Resonance (“EPR”) experiments. AmpliTech’s will leverage its proprietary cryogenic low-noise amplifier technology that operates at 5 degrees Kelvin (-450 degrees Fahrenheit), to create the requested probe. The amplifier technology has a low power dissipation and can also be used in quantum computing, nanophysics, and astronomy applications. The exclusive manufacturer for the product will be AmpliTech, with Amplify My Probe having the sole global distribution rights for a term of at least 18 months. Other possible applications include speeding up new drug design, increasing efficiency in catalytic processes, and discovering new materials for future quantum computers. According to Dr. Simenas Mantas, one of the Amplify My Probe team members who designed the EPR cryogenic probe, the device is expected to significantly speed up EPR experiments by amplifying microwave signals and suppressing source noise. We anticipate close to 100x speedup of the experiments. Such an improvement is highly relevant in the field as it will significantly expand the domain of systems that can be studied by EPR. Among such systems are biomolecules, catalytic surfaces, materials for quantum computing and others,” Dr. Mantas added. AmpliTech CEO Fawad Maqbool added that his company was looking forward to working with Amplify My Probe to help develop this innovative new product that will advance materials science and medical technology. “AmpliTech Group, Inc. is dedicated to being a driving force and leader in amplifier technology for communications and microwave applications that are part of everyday life around us,” Maqbool said. This contract has the potential to help strengthen AmpliTech’s position in an expanding market and pave the way to new opportunities for growth in the future. The global market for RF components in 2020 was valued at $23.79 billion, and is expected to grow at a CAGR of 14% through 2025, resulting in an estimated $45.05 billion market (https://ibn.fm/26TSZ). The company has plans to be a facilitator for enhancing, developing, and distributing breakthroughs in the following markets:

• High speed terrestrial and satellite terminals (SATCOM, “Internet in the Sky”)
• IoT (Internet of Things)
• Quantum supercomputers and research
• Autonomous self-driving vehicles
• Drones, AUVs (unmanned aerial vehicles)
• Military and defense ECM/EW
• 5G/Wi-Fi6E and 6G wireless infrastructure (cellular base stations, small cells, private Wi-Fi networks)
• Cloud farms, big data, and MEC architecture
• Deep space astronomy
• Telemedicine, AR/VR (augmented and virtual reality)
• Cybersecurity

AmpliTech recently announced that since the company uplisted to NASDAQ on February 17, 2021, it has raised more than $30 million in capital. The company believes that this is a sign of validation of its strategic growth plan among the investment community (https://ibn.fm/wDoNo). “We are pleased to see the level of interest by so many investors in these capital raises,” Maqbool said. “We have raised this capital to strengthen the Company financially and thus be better positioned to fulfill larger orders and broaden our customer base.” With the proceeds, AmpliTech plans to allocate funding, funneling it into specific endeavors. Among the potential uses of the $30 million raised, the company plans to focus on:

• Funding organic growth by sales force expansion and boosting the business development and marketing efforts,
• Expanding the production capabilities while strengthening the operations team,
• Making strategic acquisitions or acquire complementary intellectual properties,
• Funding additional research and development efforts to sustain continued organic growth, and
• Purchasing capital equipment to increase production efforts for productivity and engineering support.

The current investments into AmpliTech allow the company to pay down debt and use cash (and non-dilutive methods) for M&A activities aimed at building a world that the company envisions sustaining through its proprietary technology designed to improve everyone’s quality of life – whether it be through smart homes, cities, or high-speed 5G connectivity. For more information, visit the company’s website at www.AmpliTechInc.com. NOTE TO INVESTORS: The latest news and updates relating to AMPG are available in the company’s newsroom at https://ibn.fm/AMPG

June 3-4th, 2021 DGE’s Risk-Based Quality Management Summit June 3-4th, 2021 On 3rd -4th June 2021, biopharma and medical device companies are invited to attend the Live Streaming of the Risk-Based Quality Management Summit. The event is hosted by Dynamic Global Events (“DGE”), a Life Science Leader in organizing B2B Events. The Global Event Company caters to the dynamic informational and networking needs of the Pharmaceutical, Biotechnology, Healthcare, Medical Devices, and allied industries. The 2-day event will start with the chairperson’s opening remarks followed by a keynote on World-Class Enterprise Risk Evaluation and Adaptive Monitoring provided Andy Lee, SVP, Head of Global Clinical Trials Operations at Merck Research Laboratories. Experts will share insights proactive risk management, quality my design and data monitoring. This Summit aims to discuss risk tolerance and agility in clinical trial oversight. The RBQM Summit will provide all the latest information that will help reduce the complexity and costs associated with clinical trials, cutting down the risks involved, to derive the maximum output from the R&D budget. The Risk-Based Quality Management Summit will include two sessions on COVID-19 with Phi Tat, Central Monitoring Manager, Pfizer (NASDAQ: PFE), and Jennifer Goewey, Associate Director, Risk Management-Central Monitoring, Janssen R&D, to address the impact of COVID19 on trials. The Summit will focus on complex issues, including: o How to design a comprehensive RBQM master plan on Streamline a “culture of quality” for proactive risk management to Discern the realities of applying Six Sigma to clinical research to Assess the situation when thresholds are exceeded and whether subsequent data are still valid to Evaluate remote monitoring of data and examine changes in clinical trial landscape post COVID-19 o Exacting a risk-based audit strategy and prepare to ensure inspection readiness The distinguished speaking faculty of the Summit consists of 15 imminent influencers from the pharma industry and risk-management experts. Andy Lee, Merck Research Laboratories, SVP, Head of Global Clinical Trials Operations; Andy Lawton, Risk-Based Approach Ltd, Consultant; Angela Repa, bluebird bio (NASDAQ: BLUE), Senior Director, Proactive Clinical Excellence; Anne Lawrence, AbbVie (NASDAQ: ABBV), Executive Director Site Management Operations; Celeste Gonzalez, Boston Scientific, Principal Specialist, Clinical Quality Assurance and Compliance; Shawntel Swannack, GSK (NASDAQ: GSK), Central Monitoring, to name a few. In these uncertain times, this Summit offers in depth and fresh perspectives on RBQM. It will provide an opportunity for World-Class Risk Evaluation and Adaptive Integrated Monitoring that will help conserve energy and resources and maintain agility in clinical trial oversight. For more information regarding the event, please visit https://ibn.fm/6bglf

• Consequences of novel Coronavirus infection on brain health are significant, requiring frequent brain monitoring
• Brain diagnostics in infected patients extremely limited due to their severe physical illnesses; traditional EEG time consuming, exposes frontline workers to virus transmission risk
• BRSF’s sanitary disposable NeuroCap(TM) helps health care workers get quick, reliable insights into patient’s condition while minimizing cross-contamination risk

Brain Scientific (OTCQB: BRSF), a commercial-stage healthcare company providing next-gen solutions to the neurology market, is poised to offer a response to brain diagnostic challenges in the hospitals’ red zones amid the pandemic. As the Company describes in one of the recent articles published on the website, the consequences of the COVID-19 pandemic on brain health are significant (https://ibn.fm/fhYxm).

While respiratory damage of novel Coronavirus is well reported, debilitating and even deadly neurological conditions may be affecting far more people infected with the virus. As the pandemic unravels and we learn more about the COVID-19, it is becoming clear that, although COVID-19 does not appear to directly attack nerve tissue, it is neurologically damaging. It is known to cause neurological injury in 1 out of 7 patients hospitalized with the infection (https://ibn.fm/aTUhK). The list of neurological diseases associated with COVID-19 infection is long and includes encephalopathy, Guillain-Barré syndrome, hemorrhagic stroke, ischemic stroke, meningoencephalitis, paralysis, and seizures. A growing body of evidence suggests that COVID-19 can have serious and potentially long-lasting effects on the brain — as many as 1 in 3 COVID-19 survivors experience neurological or a mental health disorder within six months of the infection (https://ibn.fm/Bop48).

COVID-19 appears to cause neurological injury through three mechanisms, including hypoxemia — the state of very low blood oxygen levels causing encephalopathy and neurological damage; immune dysfunction causing “cytokine storm” and blood clots.

Neurological conditions associated with COVID-19 are challenging to diagnose. For example, the diagnosis of encephalopathy, one of the most frequently occurring neurological conditions in COVID-19, is mainly clinical and heavily hindered by the severe physical illnesses of hospitalized infected patients. Investigative procedures such as MRI, lumbar puncture and cerebrospinal fluid analysis are complicated to perform on ICU patients that are on supportive care measures such as mechanical ventilation and supplemental oxygenation.

The quest for a diagnostic procedure that may offer a response in this extremely difficult and limiting setting is still ongoing – but EEG may be able to offer a solution.

EEG could be a potentially helpful study to conduct on patients with suspected COVID-19 encephalopathy. Bedside EEG testing may reveal occult, subclinical seizure activity that would otherwise go unveiled. Still, traditional EEG testing is a time-consuming task that requires placing electrodes and measuring the patient’s head, which all prolongs exposure of frontline health workers to the deadly virus.

When fighting a highly contagious disease, disposable technology is vital. This is where NeuroCap(TM) and NeuroEEG(TM), the Company’s two FDA-cleared devices, can help. They offer cost-efficient, portable neurological monitoring. With sanitary, disposable EEG caps, BRSF’s revolutionary solution helps health care workers get a quick, reliable picture of a patient’s condition while ensuring that the virus is not spread through equipment. BRSF’s EEG caps designed for single use are also easy to place – within minutes – which helps shorten person-to-person exposure, minimizing cross-contamination risk between staff and patients.

For more information, visit the company’s website at www.BrainScientific.com/Invest-Now.

NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://ibn.fm/BRSF

• The BevCanna team has decades of combined experience creating, branding and manufacturing iconic brands that resonate with consumers on a global scale
• BevCanna owns and operates world class infrastructure, including a 40,000-square-foot, HACCP certified manufacturing facility with a current bottling capacity of up to 210 million bottles per year for both traditional and cannabis-infused beverages, and an alkaline spring water aquifer located onsite
• The company delivers a diverse portfolio of beverages and nutraceuticals for both in-house brands and white labeled products
• BevCanna leverages a proven direct-to-consumer e-commerce strategy to sell a range of natural health products throughout North America and Western Europe
• The company has provided strong revenue guidance through multiple streams, including white labeling, joint-ventures, licensing, brand building and e-commerce direct to consumer

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) is a diversified health & wellness beverage and natural products company focused on developing and manufacturing a range of plant-based and cannabinoid beverages and supplements for both in-house brands and white-label clients. The BevCanna team boasts decades of experience creating, manufacturing and distributing iconic brands that resonate with consumers on a global scale. BevCanna’s distribution network features more than 3,000 points of retail distribution through the company’s market-leading TRACE brand, its Pure Therapy natural health and wellness e-commerce platform, its fully licensed Canadian cannabis manufacturing and distribution network and its partnership with #1 U.S. cannabis beverage company Keef Brands. Based in British Columbia, Canada, BevCanna was founded in 2017. End-to-End Turnkey Beverage Manufacturing Solutions BevCanna is a manufacturer of traditional and cannabis-infused beverage brands serving a growing roster of white-label clients, in addition to operating a portfolio of in-house and partner brands. The company offers a full-service white label beverage manufacturing solution.

• Processing – At its state-of-the-art beverage manufacturing facility, BevCanna partners with industry leaders specializing in crude extraction, refinement, purification and solubility conversion to provide high-quality water-immiscible emulsions that maximize bioavailability, clarity and taste.
• Spring Water – BevCanna directly owns a pristine naturally alkaline spring water aquifer in British Columbia.
• Product Development – BevCanna leverages its expertise to develop captivating flavors based on category and consumer insights in order to enhance product positioning.
• Packaging – A variety of packaging options are offered by BevCanna, including beverage and nutraceutical formats such as PET, aluminum and glass, available in a variety of standard and custom sizes and shapes.
• Beverage Manufacturing: Traditional & Cannabis Facilities – The company’s 40,000-square-foot beverage manufacturing facility is HACCP (Hazard Analysis Critical Control Point) Certified. The facility’s capabilities include blow molding, dosing, carbonation options, filling and capping, pressure sensitive and shrink-sleeve label applications, flash pasteurization, QA testing and packing/palletizing for shipment.

Pure Therapy, TRACE and Partner Brands BevCanna’s in-house brands include Pure Therapy and TRACE. Pure Therapy is a direct-to-consumer e-commerce brand that markets a range of natural health products, including nutraceuticals and hemp-based cannabidiol (“CBD”) products, throughout North America and Western Europe. Pure Therapy has secured orders from over 23,000 customers since its inception in 2017. BevCanna expects strong growth through Pure Therapy over the next 12 months driven by new product integration, accelerated growth of existing products and its marketing team’s e-commerce expertise. TRACE products feature the Naturo Group’s proprietary plant-based fulvic and humic mineral formula, sourced from deep within the Rocky Mountains of interior British Columbia. These unique and ancient minerals provide wellness properties that include iron, magnesium, calcium, potassium and many other minerals no longer found in our food chain at adequate levels. Research suggests that the proprietary fulvic and humic organic compounds found in TRACE products could offer a number of key benefits, including promoting gut health, immune function, cognitive performance and whole-body wellness. TRACE products include Natural Alkaline Spring Water, Plant-Based Mineralized Spring Water, Natural Flavor Sparkling Spring Water, Plant-Based Mineral Concentrate with Vitamin D and Plant-Based Mineralized Immune Support Shots. In addition to its in-house brands, BevCanna provides white-label services to a number of partners in its space. BevCanna’s current portfolio of brand partnerships includes #1 U.S. cannabis beverage brand Keef (cannabis-infused classic soda) and BLOOM (live resin & high-end extracts). BevCanna also has multiple white label agreements to co-manufacture branded beverages. Market Outlook for Cannabis-Infused Beverages In 2018, the cannabis-infused beverage market was valued at $901.8 million. The market is expected to grow during the forecast period of 2019 to 2025 at a CAGR of 17.8%, resulting in a market value in excess of $2.84 billion by 2025, according to Grand View Research (https://ibn.fm/VkJfH). The projected growth is largely attributed to the legalization of recreational and medical marijuana in multiple jurisdictions. Cannabis-infused beverages are uniquely positioned to provide an alternative to a large portion of the edibles market, including items such as chocolates, cookies, gummies and other types of confectionery pieces. Management Team Marcello Leone is the CEO and Founder of BevCanna. He is also the founder of Naturo Group and the TRACE brand. John Campbell is the CFO and CSO of BevCanna. He has over 30 years of experience in the investment industry, including time with TriView Capital Ltd. Keith Dolo is the company’s Executive Management Advisor, having previously served as CEO and Executive Chairman of Sproutly Inc. Previously, he served for over 13 years with Robert Half (NYSE: RHI), an S&P 500 company, specifically in the role of Vice President for the last eight years. Melise Panetta is the company’s President. She is an accomplished senior marketing and sales executive with extensive experience leading organizations such as SC Johnson, General Mills (NYSE: GIS) and PepsiCo (NASDAQ: PEP). Ms. Panetta has nearly 15 years of deep marketing and sales expertise. Raffael Kapusty is the company’s Vice President of Sales & Insights. She is an accomplished CPG industry leader with more than 25 years of experience in both the Canadian and U.S. retail spaces. With a solid foundation at ACNielsen Canada (NYSE: NLSN), Ms. Kapusty has developed a deep understanding of the CPG space, working with over 100 leading Canadian & global CPG manufacturers. She has also held senior category and key account management roles at Kroger (NYSE: KR), SC Johnson and Unilever Canada (NYSE: UL). Bill Niarchos is the company’s Vice President of Sales & Sales Operations. He has over 20 years of experience in the CPG goods industry/retail environment. In his most recent role as Director of Sales with Bayer Consumer Health, Mr. Niarchos managed the strategic direction and growth of Loblaw & SDM. Prior to his position with Bayer (ETR: BAYN), Mr. Niarchos held a number of progressive roles at Colgate Palmolive (NYSE: CL) for more than 14 years. Japheth Noah is the company’s Head of Quality Assurance. He is an Oxford and MIT educated quality and regulatory manager with over 15 years of experience in the beverage, pharmaceutical, natural health and medical industries. Keith Stride is the company’s Creative Director. He has 25 years of experience in marketing and advertising, including time in a CMO role with Hemptown USA. Mr. Stride is internationally recognized for building high-profile brands, including Rogers (NYSE: RCI), TD Bank (NYSE: TD), Best Buy (NYSE: BBY), Whistler-Blackcomb and RBC (NYSE: RY). For more information, visit the company’s website at www.BevCanna.com. NOTE TO INVESTORS: The latest news and updates relating to BVNNF are available in the company’s newsroom at http://ibn.fm/BVNNF

• Nextech recently signed a letter of intent to acquire all outstanding shares of Threedy.ai Inc. Threedy’s AI-enabled technologies create 3D models from 2D images through a six-stage assembly line, integrated into a single platform. Nextech intends to assimilate Threedy’s platform into its AR ecosystem
• The company also announced it has been designated as the preferred vendor by Visit Tampa Bay, a not-for-profit organization
• NTAR recently launched “LiveX,” its Digital Experience Platform, and plans to showcase it in a June 29 signature event featuring Gary Vee as the keynote speaker

Toronto-based Nextech AR Solutions (CSE: NTAR) (OTCQB: NEXCF) recently announced it has signed a binding LOI to acquire all outstanding shares of California-based Threedy.ai Inc (“Threedy”). The acquisition, expected to be completed mid-June, will be based on an all-stock offer in which US$9.5 million worth of Nextech’s common shares will be issued to Threedy’s shareholders (https://ibn.fm/bg5PZ). Founded in 2018, Threedy envisions a commerce world wherein every physical product has an exact 3D digital replica. To achieve this vision, the startup builds proprietary artificial intelligence (“AI”) technologies and computer vision innovations that create 3D models of physical products from 2D photos at scale through a six-stage assembly line. The 3D model creation process, carried out within a single integrated platform, starts with the automatic onboarding of product photos using a simple JavaScript tag. The AI then creates 3D models of each item, which are hosted on Threedy’s cloud. The platform subsequently serves 3D visualizations using web-based augmented reality (“AR”) or 3D viewing applications. These steps can be summarized as ingest, segment, create, paint, assemble, and package. This AI-enabled product, coupled with the guidance of the leadership team comprising seasoned entrepreneurs and scientists, has enabled Thready to forge relationships with many clients in the commerce industry, including Wayfair, Walmart, Lighting Plus New Zealand, K-mart Australia, Kohl’s Pier 1 Imports, and more. With the buyout, which is part of Nextech’s acquisition strategy to create new revenue opportunities and grow, Nextech intends to assimilate Threedy’s AI-powered integrated platform into its AR ecosystem. It envisions that this product will become the self-service AR platform for all its AR solutions, which include holograms, AR portals, e-commerce, AR advertising, and more. Further, the acquisition will enable both Nextech and Threedy to bridge the content creation gap between 2D and 3D and center AI technology within the digital transformation economy. “With Threedy’s technology and Nextech’s global sales and marketing machine, our combined AI teams, and our existing AR tech and resources as a public company, I’m convinced that we will quickly take a leadership position in the AR industry,” stated Nextech CEO Evan Gappelberg. As a developer of a better industry solution for creating 3D models and content, Threedy is well placed to scale with the rapid adoption of AR around the world. In fact, the startup’s game-changing product is the first ever to create digital replicas easily, fast, and cost-effectively manner. It, therefore, significantly benefits major retailers and manufacturers, which, for a long time, could not expand their 3D digital inventories fast enough and cost-effectively. At the time, the biggest bottleneck used to be the inability to create 3D models at a scale. But not any longer. Elsewhere, Nextech also made two notable announcements recently, the first being that it has been chosen as the preferred vendor by Visit Tampa Bay, a not-for-profit organization that encourages visitors to unlock the sun, fun, and culture in Florida’s most diverse travel destination (https://ibn.fm/mWniD). While the partnership mainly concerns Nextech’s e-commerce segment, it is strategic because it extends the company’s reach by providing an opportunity to connect with confirmed conferences to host virtual and hybrid events on its virtual experience platform (“VXP”). Additionally, on May 12, NTAR released its Digital Experience Platform, “LiveX”, the AR industry’s first-ever all-in-one platform that supports AR advertising, AR e-commerce, AR products, and augmented digital experiences. The company plans to showcase LiveX in a signature event, dubbed “LiveNow,” to be held Tuesday, June 29, 2021, at 10 am Eastern Time (https://ibn.fm/foRW2). LiveNow will feature entrepreneur and internet personality Gary Vaynerchuk (better known as Gary Vee) as the keynote speaker. For more information, visit the company’s website at www.NextechAR.com. NOTE TO INVESTORS: The latest news and updates relating to NEXCF are available in the company’s newsroom at https://ibn.fm/NEXCF

• Sequire Investor Community designed to act as community hub for millions of retail and institutional investors currently engaging with the Sequire platform
• Sequire recently released details of its extensive conference schedule, which will cover themes including cannabis, blockchain, clean tech, fintech, and micro-cap equities
• SRAX also introduced addition of Morgan-Lea Fogg, who will be joining SRAX team as community development manager charged with Sequire Investment Community creation

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, has announced the launch of the Sequire Investor Community, an information hub and interactive environment designed to cater to the platform’s growing network of investors (https://ibn.fm/3aDBb). The Sequire Investor Community will seek to function as a bustling, synergetic community hub for the millions of retail and institutional investors currently engaging within the Sequire platform. To support the rising number of investors on its platform, Sequire will seek to create a live and on-demand virtual space, enabling investors to congregate to learn, share and network on a wide range of industry related topics. The launch of the Sequire Investor Community comes shortly after the Company’s release of its extensive upcoming conference schedule for the year (https://ibn.fm/UONdG). Devised to add further value to the millions of investors and shareholders currently using its platform, Sequire’s slate of upcoming conferences will include events such as the LD Micro Invitation XI (June 8-10), the Sequire Blockchain Conference (July 15), the Sequire Edtech Conference (September 13), and the Sequire Clean Tech / EV Conference (October 14), among various others. “We are excited to kick off our conference series and to provide our Sequire clients a platform to reach a large audience of both retail and institutional investors,” stated SRAX CEO and Founder Christopher Miglino. In addition to hosting industry specific conferences within the platform’s Virtual Event space, Sequire also plans to host a variety of educational masterclasses while simultaneously publishing a series of value-added newsletters on topics such as technical and fundamental investing with the help of LD Micro, SRAX’s micro-cap focused subsidiary. “We are leveraging the investors and experts from the LD Micro community to enhance relationships and communications with investors,” continued Miglino. “In addition to the LD Micro investor events, we’re hosting industry specific conferences, and planning a variety of resources and experiences to benefit this growing community.” SRAX also announced that Morgan-Lea Fogg had joined the SRAX team as Community Development Manager, charged with the creation of the Sequire Investor Community. Fogg, who was previously at Summit Series, an organization designed to foster global communities through invitation-only events, brings over seven years of experience within the event planning and community creation space to her new role. Morgan-Lea Fogg said in relation to the Sequire Investor Community, “Our goal is that the Sequire Investor Community will become a well-known hub, providing exceptional tools and experiences that will allow people to learn and participate in the everyday activity happening within the stock market.” For more information, visit the company’s website at www.SRAX.com. NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

• Florida is the third-largest market by revenue in the US, bringing in over $1.2 billion in 2020 for medical cannabis
• Once the acquisition of Acreage Holdings is finalized, RWB will mobilize 30 turn-key grow pods for cultivation
• RWB acquired licenses to open 35 dispensaries in Florida, a limited license state, more than doubling the current number there

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a super state operator of American Cannabis, targets individual states in the United States, dominating one state before expanding into another. The company’s commitment exceeds the requirements of each state in which it operates. Beginning in Michigan, RWB currently has its eyes on the third largest market by revenue in the United States, Florida. “Our core strategy has always been to focus on a limited number of markets within which to operate at scale, and Florida has always been one of those targeted markets,” stated Brad Rogers, Chief Executive Officer of RWB. In February, RWB announced the acquisition of Florida operations from Acreage Holdings that included eight leased locations and the ownership of a 113,000 square feet cultivation and processing facility on 15 acres of land (https://ibn.fm/Fl7jD). Once the acquisition is completed, RWB plans to increase cultivation capacity. The majority of Florida’s medical cannabis market is mass produced flower of common strains. And still, the state has one of the strongest markets in the US, with revenue reaching over $1.2 billion in 2020.  RWB is looking to meet Florida’s demand for a more premium product and has acquired 30 double wide fully enclosed cultivation pods to help expedite production to support store openings. The company has already obtained licenses to open 35 dispensaries in the state (https://ibn.fm/yA8xZ), an accomplishment in a limited license state with only 22 licensed operators (https://ibn.fm/6S3En). Once online, these pods will provide around 19,000 square feet of operating space with a 14,400 square feet canopy. Combined, they can produce over 7000lbs of flower and thousands of pounds of trim yearly. The estimated annual value that these units will produce is $40 million (https://ibn.fm/PqfVS). From the beginning, RWB has followed a top-down approach to cultivation developed under the guidance of scientific experts in growing principles. By using science-driven production methods and automated, sustainable manufacturing practices, they can operate at an industrial scale. Red White & Bloom adheres to the highest ethical, manufacturing, education, branding, and employment standards available in the industry. Through strategic acquisitions, a super state operator model, and a commitment to top-quality on every level, RWB is positioned to become one of the top three multi-state cannabis operators in the US legal cannabis and hemp markets. For more information, visit the company’s website at www.RedWhiteBloom.com. NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://ibn.fm/RWBYF